Treatments & interventions

therapy

Observed in 335 articles across 42 journals.

Steady

Latest share1.00%

Change vs baseline+0.04 pp

Months observed13

Latest monthJul 2026

Portfolio article share

Attention over this snapshot

13 monthly points

Journal breadth

Where it appears

Journal for ImmunoTherapy of Cancer70
BMJ Open30
Gut28
BMJ Case Reports25
Heart23
European Journal of Hospital Pharmacy17
Thorax17
Journal of NeuroInterventional Surgery12
Lupus Science & Medicine11
BMJ10
BMJ Open Respiratory Research10
BMJ Paediatrics Open8

Co-occurrence

Explore nearby topics

Inspect the source signal

Article evidence

30 high-ranking examples

Journal for ImmunoTherapy of Cancer · 2025-11-04

767 Type 1 conventional dendritic cell therapy coordinates tumor control in murine melanoma

Phrase rank #1 · DOI 10.1136/jitc-2025-SITC2025.0767

JME Practical Bioethics · 2026-06-02

Market approval and the right to health: a human rights perspective on MDMA-assisted therapy

Phrase rank #2 · DOI 10.1136/jmepb-2025-000039

BMJ Open · 2026-04-24

Effectiveness of an online interval group therapy for children with developmental language disorders: protocol for a randomised controlled intervention study

Phrase rank #2 · DOI 10.1136/bmjopen-2025-099997

Journal for ImmunoTherapy of Cancer · 2025-11-04

611 RP1 plus nivolumab in patients with and without prior BRAF-directed therapy: a subgroup analysis of patients with anti-PD-1-failed BRAF-mutant melanoma from the IGNYTE clinical trial

Phrase rank #2 · DOI 10.1136/jitc-2025-SITC2025.0611

Heart · 2025-10-05

Underdosing in antithrombotic care: rethinking ‘less’

Phrase rank #2 · DOI 10.1136/heartjnl-2025-327052

Journal of NeuroInterventional Surgery · 2026-07-19

E-315 Efficacy and Safety of an early aggressive lipid-lowering strategy using triple therapy after mechanical thrombectomy

Phrase rank #3 · DOI 10.1136/jnis-2026-SNIS.419

Journal of Scleroderma and Related Disorders · 2026-06-05

OC.03 Initial therapy in SSC-PAH improves outcomes across haemodynamic thresholds and risk stratification: insights from the EUSTAR database

Phrase rank #3 · DOI 10.1136/JSRD-2026-SSWC.3

Heart · 2026-03-25

Comparative analysis of recurrence rates following various cessation strategies for rilonacept in recurrent pericarditis

Phrase rank #3 · DOI 10.1136/heartjnl-2024-325515

Journal for ImmunoTherapy of Cancer · 2026-01-30

Partitioned overall survival: comprehensive analysis of survival states over 4 years in CheckMate 9ER comparing first-line nivolumab plus cabozantinib versus sunitinib in advanced renal cell carcinoma

Phrase rank #3 · DOI 10.1136/jitc-2025-013546

BMJ Open · 2026-01-19

Impact of vitamin D non-reimbursement policy on therapy discontinuation in the general and rheumatic population in the Netherlands: a cross-sectional study

Phrase rank #3 · DOI 10.1136/bmjopen-2025-105497

Journal for ImmunoTherapy of Cancer · 2025-11-19

Precise combination therapy of radiotherapy and immunotherapy guided by joint PD-L1 imaging and T-cell imaging

Phrase rank #3 · DOI 10.1136/jitc-2025-012300

Gut · 2025-10-06

P33 Outcomes with triple therapy (ursodeoxycholic acid, fibrate and obeticholic acid) for treatment of high-risk primary biliary cholangitis

Phrase rank #3 · DOI 10.1136/gutjnl-2025-BASL.49

Gut · 2025-10-06

P44 Combination of obeticholic acid with bezafibrate, with or without ursodeoxycholic acid, in high-risk patients with primary biliary cholangitis: a single centre experience

Phrase rank #3 · DOI 10.1136/gutjnl-2025-BASL.60

Heart · 2025-08-13

4-027 Phage therapy – back to the future

Phrase rank #3 · DOI 10.1136/heartjnl-2025-BCS.139

Journal for ImmunoTherapy of Cancer · 2026-06-25

Immune checkpoint inhibitor therapy after tumor-infiltrating lymphocytes in unresectable melanoma

Phrase rank #4 · DOI 10.1136/jitc-2026-015360

Sexually Transmitted Infections · 2026-05-20

SC22 Life after long-acting therapy: what happens when CAB/RPV is discontinued?

Phrase rank #4 · DOI 10.1136/sextrans-ICAR-2026.89

BMJ Case Reports · 2026-02-05

Resolution of penile calciphylaxis in a high-risk dialysis patient with medical therapy and wound care

Phrase rank #4 · DOI 10.1136/bcr-2025-269829

BMJ Open Ophthalmology · 2025-11-02

Tracking real-world persistence and adherence to anti-VEGF intravitreal therapy with prefilled syringes: a German prescription sales analysis

Phrase rank #4 · DOI 10.1136/bmjophth-2025-002334

BMJ Supportive & Palliative Care · 2025-10-27

Music therapy in adult hospices: a national multicentre survey

Phrase rank #4 · DOI 10.1136/spcare-2025-005418

BMJ Open · 2025-10-16

Dose-averaged LET escalation with multi-ion therapy for head and neck cancers: a phase I study protocol for a prospective, open-label, single-arm, single-centre trial (MULTI-ION-HN-I)

Phrase rank #4 · DOI 10.1136/bmjopen-2024-098151

Journal of NeuroInterventional Surgery · 2025-09-02

A140 Effect of standard versus triple lipid lowering therapy after endovascular thrombectomy on functional outcomes in large vessel occlusion stroke (STYLE study): a multicenter experience

Phrase rank #4 · DOI 10.1136/jnis-2025-ESMINT.129

Frontline Gastroenterology · 2025-08-20

OC49 Tacrolimus in children with autoimmune hepatitis

Phrase rank #4 · DOI 10.1136/flgastro-2025-bspghan.49

Journal of Scleroderma and Related Disorders · 2026-06-05

P.185 Impact of immunosuppressive therapy on burden of recurrent digital ulcers in scleroderma vasculopathy

Phrase rank #5 · DOI 10.1136/JSRD-2026-SSWC.229

BMJ Open Respiratory Research · 2026-03-05

Societal and personal financial burden of severe asthma and impact of biologic therapy: a 19-year nationwide cost analysis

Phrase rank #5 · DOI 10.1136/bmjresp-2025-003867

Gut · 2026-03-03

Are the drugs already on the shelf? Repurposing therapy for pancreatitis

Phrase rank #5 · DOI 10.1136/gutjnl-2025-337879

BMJ Supportive & Palliative Care · 2025-12-04

Art therapy and caregiver anxiety, distress and well-being

Phrase rank #5 · DOI 10.1136/spcare-2024-005288

Regional Anesthesia & Pain Medicine · 2025-12-01

Clinical utility of ECAP dosing in a real-world population delivered via EVOKE therapy: the ECAP study

Phrase rank #5 · DOI 10.1136/rapm-2025-107051

Journal for ImmunoTherapy of Cancer · 2025-11-04

518 Capivasertib, an AKT inhibitor, remodels the tumor microenvironment to synergize with combination therapy of olaparib and durvalumab in susceptible advanced/metastatic solid cancers

Phrase rank #5 · DOI 10.1136/jitc-2025-SITC2025.0518

Journal for ImmunoTherapy of Cancer · 2025-11-04

203 Overcoming CART therapy resistance in an immunocompetent model of rhabdomyosarcoma

Phrase rank #5 · DOI 10.1136/jitc-2025-SITC2025.0203

Journal for ImmunoTherapy of Cancer · 2025-10-31

High-risk neuroblastoma as a model for immunotherapy of non-immunogenic cancers: where might we be in 20 years?

Phrase rank #5 · DOI 10.1136/jitc-2025-013267